January 20, 2023 – Lyon, France
Mablink Bioscience (“Mablink”) announces the publication of a review article titled “Payload diversification: a key step in the development of antibody–drug conjugates”. Its authors Louise Conilh, Lenka Kyrych Sadilkova, Warren Viricel and Charles Dumontet review the history of the successes and failures in ADC payloads and take a look at the new roads currently explored by the industry.
The article is in Open Access, you can read it here.
Conilh, L., Sadilkova, L., Viricel, W. et al. Payload diversification: a key step in the development of antibody–drug conjugates. J Hematol Oncol 16, 3 (2023).
…
Read more > https://www.mablink.com/post/a-new-review-on-the-history-and-future-of-adc-payloads-published-by-mablink-s-scientists